A holographic approach relying on small-molecule chromogens enables a rapid and inexpensive test for the accurate classification of aggressive lymphoma at the point of care.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 digital issues and online access to articles
$99.00 per year
only $8.25 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout

References
Cancer factsheet go.nature.com/2MuHccB (World Health Organization, 2018).
Yager, P., Domingo, G. J. & Gerdes, J. Annu. Rev. Biomed. Eng. 10, 107–144 (2008).
Im, H. et al. Nat. Biomed. Eng. https://doi.org/10.1038/s41551-018-0265-3 (2018).
Im, H. et al. Proc. Natl Acad. Sci. USA 112, 5613–5618 (2015).
Pathania, D. et al. Theranostics 6, 1603–1610 (2016).
Saliba, A.-E. et al. Proc. Natl Acad. Sci. USA 107, 14524–14529 (2010).
Mitchell, P. S. et al. Proc. Natl Acad. Sci. USA 105, 10513–10518 (2008).
Lawrie, C. H. et al. Br. J. Haematol. 141, 672–675 (2008).
Hsieh, C.-H. et al. Sci. Rep. 8, 10684 (2018).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kopparthy, V.L., Snodgrass, R. & Erickson, D. Holographic diagnosis of lymphoma. Nat Biomed Eng 2, 631–632 (2018). https://doi.org/10.1038/s41551-018-0291-1
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41551-018-0291-1